title: Role of transforming growth factor beta in the proliferative effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on human squamous carcinoma cells.
abstract: The highly toxic environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has recently been shown to stimulate proliferation of two human squamous carcinoma cell lines, SCC-15G and SCC-25, by decreasing the sensitivity of the cells to high density growth arrest. TCDD is known to alter the activity of several endogenous growth-regulatory compounds, and this study was undertaken to investigate the possibility that modulation of transforming growth factor beta (TGF-beta) activity might be involved in the mechanism of growth stimulation by TCDD. TGF-beta inhibited monolayer growth and DNA synthesis of SCC-15G and SCC-25 cells equally well in the presence and the absence of 10 nM TCDD. TCDD alone stimulated proliferation and inhibited differentiation in both cell lines but had no effect on binding of 125I-TGF-beta to or secretion of TGF-beta by SCC-15G cells. Inhibition of growth of SCC-15G cultures by TGF-beta was incomplete, in that cell number continued to increase even in the presence of 100 pM TGF-beta, although at a greatly reduced rate compared to non-TGF-beta-treated controls. These cells, grown in 100 pM TGF-beta alone, reached growth arrest at the same density as non-TGF-beta-treated cultures but failed to reach density-dependent growth arrest when treated with TCDD. Cells treated for 12 h with TCDD exhibited maximal induction of ethoxyresorufin-O-deethylase activity. TGF-beta inhibited this induction in a dose-dependent manner even when added after a 12-h TCDD pretreatment. The inhibition was rapidly reversible after removal of TGF-beta, indicating that it occurred via a mechanism which did not involve inhibition of very early steps in the TCDD response pathway. These results demonstrate that the stimulatory effect of TCDD on keratinocyte proliferation is not mediated through alterations in TGF-beta activity and that TCDD and TGF-beta appear to exert their opposite effects on cellular proliferation by independent mechanisms.
authors.affiliation: Experimental Toxicology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.
authors.forename: C D
authors.initials: CD
authors.lastname: Hébert
authors.forename: Q L
authors.initials: QL
authors.lastname: Cao
authors.forename: L S
authors.initials: LS
authors.lastname: Birnbaum
mesh_terms: D001692:Biological Transport / Q000187:drug effects; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D019363:Cytochrome P-450 CYP1A1; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis; D004790:Enzyme Induction / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D010088:Oxidoreductases / Q000096:biosynthesis; D000072317:Polychlorinated Dibenzodioxins / Q000378:metabolism / Q000494:pharmacology*; D011956:Receptors, Cell Surface / Q000378:metabolism; D018125:Receptors, Transforming Growth Factor beta; D016212:Transforming Growth Factor beta / Q000378:metabolism / Q000502:physiology*; D014407:Tumor Cells, Cultured
chemical_list: D000072317:Polychlorinated Dibenzodioxins; D011956:Receptors, Cell Surface; D018125:Receptors, Transforming Growth Factor beta; D016212:Transforming Growth Factor beta; D003577:Cytochrome P-450 Enzyme System; D010088:Oxidoreductases; D019363:Cytochrome P-450 CYP1A1